Related Experiment Video

Updated: Jun 8, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Anti-tumor-initiating effects of spiro-biflavonoids from Abies sachalinensis

Shun-ichi Wada1, Teppei Hitomi, Harukuni Tokuda

  • 1Laboratory of Medicinal Chemistry, Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka, Japan. wada@gly.oups.ac.jp

Chemistry & Biodiversity
|September 23, 2010
PubMed

Insights

Researchers explored coniferous tree waste for cancer chemopreventive agents. Abiesinol A from Abies sachalinensis bark demonstrated significant anti-tumor-initiating activity in mouse models, highlighting its potential in cancer prevention strategies.

Area of Science:

  • Natural Product Chemistry
  • Chemoprevention Research
  • Forestry Waste Utilization

Background:

  • Cancer chemoprevention offers a promising strategy to reduce cancer morbidity and mortality.
  • Coniferous tree byproducts are an underutilized resource for discovering novel bioactive compounds.
  • Previous research identified spiro-biflavonoids and a neolignan from Abies sachalinensis bark.

Purpose of the Study:

  • To investigate cancer chemopreventive potential of compounds derived from forestry waste.
  • To evaluate the inhibitory effects of isolated compounds on nitric oxide (NO) donor activation.
  • To assess the anti-tumor-initiating activity of abiesinol A in a mouse skin carcinogenesis model.

Main Methods:

  • Extraction and isolation of compounds from Abies sachalinensis bark.
  • In vitro screening of compounds for inhibitory effects on NOR u20051 activation (a nitric oxide donor).
  • In vivo assessment of anti-tumor-initiating activity using a two-stage mouse skin carcinogenesis test with peroxynitrite and TPA.

Main Results:

  • All tested compounds exhibited potent inhibition of NOR u20051 activation.
  • Abiesinol A demonstrated remarkable anti-tumor-initiating activity in the in vivo mouse model.
  • The study successfully identified a potential chemopreventive agent from a sustainable source.

Conclusions:

  • Compounds from Abies sachalinensis bark possess significant anti-tumor-initiating properties.
  • Abiesinol A is a promising candidate for cancer chemoprevention strategies.
  • Valorizing forestry waste can lead to the discovery of valuable bioactive compounds for health applications.

More Related Videos

Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells11:06

Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells

Published on: May 20, 2015

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.